non-infectious uveitis
Ophthalmology · 2017–2024
2decisions
1medicine
2carried consumer input
35individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| adalimumab Vision-threatening non-infectious uveitis in patients who have failed corticosteroid therapy with at least 1 immunosuppressive agent, or who have documented… | Mar 2024 | Recommended with restriction | 35 individuals Australian Rheumatology Association · Juvenile Arthritis Foundation Australia |
| adalimumab Treatment of non-infectious intermediate, posterior or panuveitis that is vision-threatening in adult patients who have had an inadequate response to… | Mar 2017 | Not recommended | input received |
Who spoke
Australian Rheumatology Association · Juvenile Arthritis Foundation Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.